Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Case 12% Improvement Relative Risk c19early.org/d Mohseni et al. Vitamin D for COVID-19 Prophylaxis Does vitamin D reduce COVID-19 infections? Retrospective 603 patients in Iran Fewer cases with vitamin D (not stat. sig., p=0.095) Mohseni et al., Nutrition & Food Science, doi:10.1108/NFS-11-2020-0421 Favors vitamin D Favors control
Do body mass index (BMI) and history of nutritional supplementation play a role in the severity of COVID-19? A retrospective study
Mohseni et al., Nutrition & Food Science, doi:10.1108/NFS-11-2020-0421
Mohseni et al., Do body mass index (BMI) and history of nutritional supplementation play a role in the severity of COVID-19? A.., Nutrition & Food Science, doi:10.1108/NFS-11-2020-0421
Aug 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 603 patients in Iran, 192 taking vitamin D supplements, showing no significant difference in COVID-19 cases in unadjusted results. IR.SHOUSHTAR.REC.1399.015.
Although the 12% fewer cases is not statistically significant, it is consistent with the significant 15% fewer cases [6‑23%] from meta analysis of the 25 cases results to date. This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of case, 12.4% lower, RR 0.88, p = 0.09, treatment 99 of 192 (51.6%), control 242 of 411 (58.9%), NNT 14.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Mohseni et al., 4 Aug 2021, retrospective, Iran, peer-reviewed, 4 authors, dosage not specified.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Clinical Nutrition ESPEN 42 (2021) 280e285 Contents lists available at ScienceDirect Clinical Nutrition ESPEN journal homepage: http://www.clinicalnutritionespen.com Original article Are history of dietary intake and food habits of patients with clinical symptoms of COVID 19 different from healthy controls? A caseecontrol study Houra Mohseni a, Shirin Amini b, *, Behnaz Abiri a, Mojtaba Kalantar c, Masoumeh Kaydani c, Barat Barati d, Elham Pirabbasi b, Faezeh Bahrami b a School of Para-medicine Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran Department of Nutrition, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran Department of Occupational Health, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran d Department of Radiologic Technology, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran b c a r t i c l e i n f o s u m m a r y Article history: Received 23 December 2020 Accepted 18 January 2021 Background: Coronavirus disease 2019 (COVID-19) is an infectious disease that put unprecedented significant strain on clinical services and healthcare systems. The aim of the present research was to assess dietary food groups and also food habits of patients with clinical symptoms of COVID 19 and healthy controls. Methods: This caseecontrol research was carried out on 505 participants (279 subjects with clinical symptoms of COVID-19 and 226 controls), in age 18e65 years. Dietary food group's intake last year was investigated by a food frequency questionnaire. Food habits were asked by a general information questionnaire. The strength of the association between food group's intakes with the odds ratios (ORs) of COVID-19 was assessed using Logistic regression models. Results: After adjusting for physical activity in the logistic regression models, intake of dough and yogurt had a significantly protective role on occurrence of COVID19 (OR ¼ 0.62; 95% confidence interval (CI) ¼ 0.44e0.87; P ¼ 0.006) (OR ¼ 0.74; 95% CI ¼ 0.56e0.98; P ¼ 0.044), respectively. No significant differences were seen in food habits between the two groups in the last year ago. Conclusions: High risk population for COVID19, advised to consume enough amount of yogurt and dough at the time of this pandemic. © 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved. Keywords: Symptoms of COVID 19 Food group's intake Food habits 1. Background Coronavirus disease 2019 (COVID-19), that puts unprecedented significant strain on clinical services and healthcare systems, is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first human cases of COVID-19 were identified in China in late December 2019 [1]. The ongoing pandemic has resulted in more than 17.5 million confirmed cases and 677, 000 deaths worldwide and there have been almost 92, 000 deaths in the Asia Region up to 1 August 2020 [2,3]. Coronaviruses * Corresponding author. Assistant professor of Nutrition, Department of Nutrition, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran E-mail addresses: amini-sh@shoushtarums.ac.ir, aminishirin83@yahoo.com (S. Amini). belong to b-coronaviruses and are transmitted through secretions of infected people such as saliva and respiratory secretions or their respiratory droplets [4,5]. The severity of clinical symptoms in positive COVID-19 patients is varied, ranging from asymptomatic to acute respiratory distress syndrome and multi-organ..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit